Matthew B. Jarpe
Matthew B. Jarpe publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Histone Deacetylase Inhibitors Research, Peptidase Inhibition and Analysis and Epigenetics and DNA Methylation.
- World rank
- #452,591 of 7,710,434 ranked researchers
- Rank in United States
- #158,919 of 1,627,098
- Works
- 57
- Citations
- 7.2k
- Citations per work
- 127.2
What does Matthew B. Jarpe research?
Matthew B. Jarpe's work is mostly in Biochemistry, Genetics and Molecular Biology (48%), Medicine (26%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3052.2%
- Health Sciences1526.3%
- Medicine1526.3%
- Everything else1221.5%
- 1Molecular Biology48% of their works
- 2Oncology10% of their works
- 3Hematology6% of their works
- 4Physiology6% of their works
- 5Genetics5% of their works
- 6Immunology4% of their works
Research topics
Which keywords describe Matthew B. Jarpe's research?
The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, Fibroblast Activation Protein, Tumor Microenvironment, BET Bromodomains, BRAF gene and Chemotherapy-Induced Peripheral Neuropathy.
- Taxanes
- PROTACs
- International Myeloma Working Group
- Diagnosis Criteria
- Chemotherapy-Induced Peripheral Neuropathy
- BET Bromodomains
- Fibroblast Activation Protein
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- Tumor Microenvironment
- BRAF gene
- DNA Methylation
- Histone Modification
- MAP Kinase
- Sickle-cell Disease
- Thalassemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cancer Therapy413 topics
- HDAC Inhibitors281 topic
- Histone Deacetylases281 topic
- Fibroblast Activation Protein71 topic
- Tumor Microenvironment71 topic
- BET Bromodomains61 topic
- BRAF gene61 topic
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- DNA Methylation61 topic
- Diagnosis Criteria61 topic
- Histone Modification61 topic
- International Myeloma Working Group61 topic
- MAP Kinase61 topic
- PROTACs61 topic
- Sickle-cell Disease61 topic
- Taxanes61 topic
- Thalassemia61 topic
Where does Matthew B. Jarpe work?
Matthew B. Jarpe's main affiliation in the publication record is Acetylon Pharmaceuticals (United States), United States.
How many publications and citations does Matthew B. Jarpe have?
OpenAlex counts 57 works and 7,250 citations for Matthew B. Jarpe, an h-index of 30, ranking #452,591 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew B. Jarpe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.